合生元
肠-脑轴
肠道菌群
焦虑
萧条(经济学)
粪便细菌疗法
医学
微生物群
肠道微生物群
生物信息学
生物
精神科
免疫学
益生菌
微生物学
细菌
艰难梭菌
经济
抗生素
遗传学
宏观经济学
作者
Akash Kumar,Jhilam Pramanik,Nandani Goyal,Dimple Chauhan,Nevin Sanlier,Dr. Bhupendra Prajapati,Chaiyavat Chaiyasut
出处
期刊:Pharmaceuticals
[Multidisciplinary Digital Publishing Institute]
日期:2023-04-09
卷期号:16 (4): 565-565
摘要
The gut microbiota is critical for maintaining human health and the immunological system. Several neuroscientific studies have shown the significance of microbiota in developing brain systems. The gut microbiota and the brain are interconnected in a bidirectional relationship, as research on the microbiome–gut–brain axis shows. Significant evidence links anxiety and depression disorders to the community of microbes that live in the gastrointestinal system. Modified diet, fish and omega-3 fatty acid intake, macro- and micro-nutrient intake, prebiotics, probiotics, synbiotics, postbiotics, fecal microbiota transplantation, and 5-HTP regulation may all be utilized to alter the gut microbiota as a treatment approach. There are few preclinical and clinical research studies on the effectiveness and reliability of various therapeutic approaches for depression and anxiety. This article highlights relevant research on the association of gut microbiota with depression and anxiety and the different therapeutic possibilities of gut microbiota modification.
科研通智能强力驱动
Strongly Powered by AbleSci AI